SLEEP–ENDO™: A stepped-care protocol for insomnia in endometriosis

Sleep disturbance is very common in people with endometriosis, and insomnia is closely linked with pain, mood and fatigue. SLEEP–ENDO™ is an author-developed stepped-care protocol that organises the management of insomnia in endometriosis into six steps: (0) recognise and characterise, (1) remove modifiable drivers, (2) deliver CBT-I as the core treatment, (3) address arousal and the pain–sleep loop, (4) consider short-term pharmacological options only if CBT-I is insufficient, (5) review and maintain. The core treatment follows the European Insomnia Guideline 2023, which recommends CBT-I as first-line treatment for chronic insomnia, including insomnia with comorbid conditions. Practical sheets translate the core components into working rules adapted to night pain, hormone-suppressing therapy and flares. In the literature searched for this protocol (November 2026), no completed randomised trial of CBT-I for insomnia specifically in endometriosis was identified, so the adaptations are extrapolations.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-11
DOI
https://doi.org/10.5281/zenodo.24133601
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SLEEP–ENDO™: A stepped-care protocol for insomnia in endometriosis

Viktoriya Hudziak
Zenodo (CERN European Organization for Nuclear Research)
Sleep and related disorders
article

SLEEP–ENDO™: A stepped-care protocol for insomnia in endometriosis

Viktoriya Hudziak
article en

Abstract

Sleep disturbance is very common in people with endometriosis, and insomnia is closely linked with pain, mood and fatigue. SLEEP–ENDO™ is an author-developed stepped-care protocol that organises the management of insomnia in endometriosis into six steps: (0) recognise and characterise, (1) remove modifiable drivers, (2) deliver CBT-I as the core treatment, (3) address arousal and the pain–sleep loop, (4) consider short-term pharmacological options only if CBT-I is insufficient, (5) review and maintain. The core treatment follows the European Insomnia Guideline 2023, which recommends CBT-I as first-line treatment for chronic insomnia, including insomnia with comorbid conditions. Practical sheets translate the core components into working rules adapted to night pain, hormone-suppressing therapy and flares. In the literature searched for this protocol (November 2026), no completed randomised trial of CBT-I for insomnia specifically in endometriosis was identified, so the adaptations are extrapolations.

Zenodo (CERN European Organization for Nuclear Research)
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon